Skip to content

TARA

Protara Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$3.94
−0.76%
Ask drillr
0
Insider buys (3m)
1
Insider sells (3m)
-$882.2K
Net value (3m)
-5.4%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 1, 2026Shefferman Jesse · director, officer: CEO and PresidentSale215,687$4.09
Jul 1, 2026Shefferman Jesse · director, officer: CEO and PresidentM-Exempt215,687$1.91
Jun 16, 2026BESHAR LUKE M · directorA-Award31,000$3.94
Jun 16, 2026Flannelly Barry P · directorA-Award31,000$3.94
Jun 16, 2026Smith Cynthia · directorA-Award31,000$3.94
Jun 16, 2026GARCEAU ROGER · directorA-Award31,000$3.94
Jun 16, 2026Huang Jane · directorA-Award31,000$3.94
Jun 16, 2026SARGEN GREGORY · directorA-Award31,000$3.94
Jun 16, 2026Solomon Michael Edward · directorA-Award31,000$3.94
Jun 16, 2026Levy Richard S · directorA-Award31,000$3.94
Apr 9, 2026Zummo Jacqueline · officer: Chief R&D OfficerSale1,134$5.40
Apr 2, 2026Zummo Jacqueline · officer: Chief R&D OfficerSale22,598$5.26
Jan 27, 2026Shefferman Jesse · director, officer: CEO and PresidentF-InKind8,732$6.67
Jan 27, 2026Fabbio Patrick · officer: Chief Financial OfficerF-InKind3,261$6.67
Jan 27, 2026Fry Hannah · officer: VP, ControllerF-InKind1,457$6.67
Jan 27, 2026Zummo Jacqueline · officer: Chf Scientific Operations OffF-InKind3,724$6.67
Jan 22, 2026Zummo Jacqueline · officer: Chf Scientific Operations OffF-InKind6,578$5.60
Jan 22, 2026Fabbio Patrick · officer: Chief Financial OfficerF-InKind3,063$5.60
Jan 22, 2026Shefferman Jesse · director, officer: CEO and PresidentF-InKind16,322$5.60
Jan 22, 2026Fry Hannah · officer: VP, ControllerF-InKind2,132$5.60
Jan 21, 2026Nicacio Leonardo Viana · officer: Chief Medical OfficerA-Award158,000$5.01
Jan 21, 2026Fry Hannah · officer: VP, ControllerA-Award9,500$0.00
Jan 21, 2026Fry Hannah · officer: VP, ControllerA-Award55,000$5.01
Jan 21, 2026Fabbio Patrick · officer: Chief Financial OfficerA-Award28,000$0.00
Jan 21, 2026CONKLING WILLIAM · officer: Chief Commercial OfficerA-Award26,000$0.00
Jan 21, 2026CONKLING WILLIAM · officer: Chief Commercial OfficerA-Award158,000$5.01
Jan 21, 2026Zummo Jacqueline · officer: Chf Scientific Operations OffA-Award30,000$0.00
Jan 21, 2026Fabbio Patrick · officer: Chief Financial OfficerA-Award175,000$5.01
Jan 21, 2026Zummo Jacqueline · officer: Chf Scientific Operations OffA-Award180,000$5.01
Jan 21, 2026Shefferman Jesse · director, officer: CEO and PresidentA-Award524,000$5.01
Institutional positioning

13F filings over the trailing two quarters

New 59Increased 99Reduced 52Sold out 18
FilerActionSharesFiled
JANUS HENDERSON GROUP PLCIncreased5,207,011May 18, 2026
Jupiter Topco LLCNew Position4,696,709Aug 14, 2026
BlackRock, Inc.Increased3,663,499Aug 7, 2026
BLACKROCK, INC.Increased3,394,968May 13, 2026
MILLENNIUM MANAGEMENT LLCIncreased3,101,166Aug 14, 2026
Velan Capital Investment Management LPIncreased2,844,652Aug 14, 2026
VELAN CAPITAL INVESTMENT MANAGEMENT LPUnchanged2,834,652May 15, 2026
MILLENNIUM MANAGEMENT LLCIncreased2,831,208May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased2,300,133Aug 13, 2026
Blackstone Inc.Unchanged2,265,514Aug 14, 2026
BLACKSTONE INC.Increased2,265,514May 15, 2026
ORBIMED ADVISORS LLCNew Position2,220,000Aug 14, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2,119,018May 15, 2026
SIO CAPITAL MANAGEMENT, LLCIncreased1,969,839May 14, 2026
Sio Capital Management, LLCReduced1,921,872Aug 14, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 1, 2026